C
KALA icon

Covestor’s KALA BIO KALA Stock Holding History

Covestor’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25
Closed – – 2663
2026
Q1 		$0 Hold
25
– – ﹤0.01% 2530
2025
Q4 		$1K Hold
25
– – ﹤0.01% 2087
2025
Q3 		$2K Buy
25
+2
+9% +$992 ﹤0.01% 1959
2025
Q2 		$5K Hold
23
– – ﹤0.01% 1751
2025
Q1 		$7K Buy
23
+4
+21% +$1.51K ﹤0.01% 1667
2024
Q4 		$7K Hold
19
– – ﹤0.01% 1663
2024
Q3 		$6K Sell
19
-2
-10% -$631 ﹤0.01% 1713
2024
Q2 		$7K Hold
21
– – ﹤0.01% 1716
2024
Q1 		$8K Sell
21
-4
-16% -$1.49K 0.01% 1706
2023
Q4 		$9K Sell
25
-2
-7% -$708 0.01% 1643
2023
Q3 		$12K Buy
27
+15
+125% +$9.84K 0.01% 1327
2023
Q2 		$9K Buy
12
+8
+200% +$6.21K 0.01% 1509
2023
Q1 		$3K Hold
4
– – ﹤0.01% 1684
2022
Q4 		$8K Sell
4
-1
-20% -$396 0.01% 1422
2022
Q3 		$3K Hold
5
– – ﹤0.01% 1621
2022
Q2 		$4K Sell
5
-1
-17% -$1.57K ﹤0.01% 1471
2022
Q1 		$19K Sell
6
-1
-14% -$2.62K 0.01% 1078
2021
Q4 		$21K Buy
+7
New +$32.5K 0.03% 848

Other funds holding KALA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Covestor's KALA Position: Q2 2026 in Review

Covestor sold out of KALA BIO (KALA) in Q2 2026, closing a stake of 25 shares.

Covestor first reported a position in KALA in Q4 2021 and held it in 18 quarters. The position peaked at $21K in Q4 2021. 14 funds tracked by Wall St. Rank hold KALA as of Q2 2026.

  • Covestor reported no remaining KALA BIO position as of Q2 2026 after selling out during the quarter.
  • Covestor sold 25 KALA BIO shares in Q2 2026.
  • Covestor first reported a position in KALA BIO in Q4 2021 and held it in 18 quarters.
  • Covestor's KALA BIO position peaked at $21K in Q4 2021.
  • 14 funds tracked by Wall St. Rank held KALA BIO as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.